Uren A - Search Results

1

Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells.

Uren A, Merchant MS, Sun CJ, Vitolo MI, Sun Y, Tsokos M, Illei PB, Ladanyi M, Passaniti A, Mackall C, Toretsky JA. Uren A, et al. Oncogene. 2003 Apr 17;22(15):2334-42. doi: 10.1038/sj.onc.1206330. Oncogene. 2003. PMID: 12700668

2

Identification of a domain within the carboxyl-terminal region of the beta platelet-derived growth factor (PDGF) receptor that mediates the high transforming activity of PDGF.

Uren A, Yu JC, Li W, Chung IY, Mahadevan D, Pierce JH, Heidaran MA. Uren A, et al. J Biol Chem. 1996 May 10;271(19):11051-4. doi: 10.1074/jbc.271.19.11051. J Biol Chem. 1996. PMID: 8626645 Free article.

3

Oncogenic activation of the alphaPDGFR defines a domain that negatively regulates receptor dimerization.

Uren A, Yu JC, Karcaaltincaba M, Pierce JH, Heidaran MA. Uren A, et al. Oncogene. 1997 Jan 16;14(2):157-62. doi: 10.1038/sj.onc.1200810. Oncogene. 1997. PMID: 9010217

4

Preparation of F-18 labeled annexin V: a potential PET radiopharmaceutical for imaging cell death.

Toretsky J, Levenson A, Weinberg IN, Tait JF, Uren A, Mease RC. Toretsky J, et al. Among authors: uren a. Nucl Med Biol. 2004 Aug;31(6):747-52. doi: 10.1016/j.nucmedbio.2004.02.007. Nucl Med Biol. 2004. PMID: 15246365

5

Wnt/Frizzled signaling in Ewing sarcoma.

Uren A, Wolf V, Sun YF, Azari A, Rubin JS, Toretsky JA. Uren A, et al. Pediatr Blood Cancer. 2004 Sep;43(3):243-9. doi: 10.1002/pbc.20124. Pediatr Blood Cancer. 2004. PMID: 15266408

6

Recombinant EWS-FLI1 oncoprotein activates transcription.

Uren A, Tcherkasskaya O, Toretsky JA. Uren A, et al. Biochemistry. 2004 Oct 26;43(42):13579-89. doi: 10.1021/bi048776q. Biochemistry. 2004. PMID: 15491164

7

Pediatric malignancies provide unique cancer therapy targets.

Uren A, Toretsky JA. Uren A, et al. Curr Opin Pediatr. 2005 Feb;17(1):14-9. doi: 10.1097/01.mop.0000147904.84978.ae. Curr Opin Pediatr. 2005. PMID: 15659957 Review.

8

PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's Sarcoma tumorigenesis.

Abaan OD, Levenson A, Khan O, Furth PA, Uren A, Toretsky JA. Abaan OD, et al. Among authors: uren a. Oncogene. 2005 Apr 14;24(16):2715-22. doi: 10.1038/sj.onc.1208247. Oncogene. 2005. PMID: 15782144

9

Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression.

Uren A, Fallen S, Yuan H, Usubütün A, Küçükali T, Schlegel R, Toretsky JA. Uren A, et al. Cancer Res. 2005 Jul 15;65(14):6199-206. doi: 10.1158/0008-5472.CAN-05-0455. Cancer Res. 2005. PMID: 16024621

10

Ewing's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent.

Uren A, Toretsky JA. Uren A, et al. Future Oncol. 2005 Aug;1(4):521-8. doi: 10.2217/14796694.1.4.521. Future Oncol. 2005. PMID: 16556028 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters